LCDX — Caliber Imaging & Diagnostics Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $11.66m
- $3.34m
2009 December 31st | 2010 December 31st | C2011 December 31st | 2012 December 31st | 2013 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Other Revenue | |||||
Total Revenue | 2.3 | 2.63 | 3.58 | 2.43 | 3.34 |
Cost of Revenue | |||||
Gross Profit | 1.14 | 1.48 | 1.69 | 0.033 | 0.654 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.85 | 6.26 | 12.9 | 12.5 | 8.11 |
Operating Profit | -3.54 | -3.63 | -9.32 | -10 | -4.77 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.05 | -4.3 | -9.05 | -9.82 | -5.48 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.05 | -4.3 | -9.05 | -9.82 | -5.48 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.05 | -4.3 | -9.05 | -9.82 | -5.48 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -4.05 | -4.3 | -16 | -9.82 | -5.48 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.555 | -0.568 | -6.1 | -1.17 | -0.663 |
Dividends per Share |